The Accreditation Commission for Health Care (ACHC) has partnered with the Immunoglobulin National Society (IgNS) to launch ...
Allergic diseases represent a major global health burden, placing significant strain on healthcare systems worldwide. Severe conditions such as anaphylaxis, asthma, food allergy, and allergic rhinitis ...
Treatment with omalizumab offers modest protection from allergic reactions to individuals with multiple food allergies, and baseline immunoglobulin E (Ig E) levels are associated with success, based ...
Omalizumab treatment allows most children with immunoglobulin E-mediated food allergy to complete oral food challenges and undergo dietary introduction.
The Accreditation Commission for Health Care (ACHC) has partnered with the Immunoglobulin National Society (IgNS) to launch the Distinction in Immunoglobulin Therapy.
The survey process was led by Amerita’s Director of Quality and Accreditation Kayla Ortlip, PharmD, IgCP, MBA. It resulted in the company receiving this distinction with zero deficiencies, ...
Please provide your email address to receive an email when new articles are posted on . 68% of patients given Xolair tolerated 600 mg of peanut protein after 16 to 20 weeks of treatment. Further ...
AOM Infusion (“AOM”), a leading provider of specialty infusion care and pharmacy services, announced today that it has earned the Distinction in Immunoglobulin (Ig) Therapy from the Accreditation ...
Local immunoglobulin levels were found to be significantly higher in polyp tissue specimens, but not in the blood, of patients with nasal polyps. Nasal polyp development may be associated with ...
The history of treating disease with antibodies began in the 1800s after tetanus and diphtheria toxins were discovered, leading to the realization that immunity to the infections caused by these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results